Jun Ho Jang

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

Keith W. Pratz, Brian A. Jonas, Vinod Pullarkat et al. · Journal of Clinical Oncology · 2021 · 156 citations · Full text

Electrochemical Synthesis of Glycine from Oxalic Acid and Nitrate

Jeong Eun Kim, Jun Ho Jang, Kyumin Lee et al. · Angewandte Chemie International Edition · 2021 · 143 citations

Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry

Jong Wook Lee, Jun Ho Jang, Jin Seok Kim et al. · International Journal of Hematology · 2013 · 127 citations · Full text

Thrombosis, Hemodialysis, Venous Thrombosis +14

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

David P. Steensma, Pierre Fenaux, Koen Van Eygen et al. · Journal of Clinical Oncology · 2020 · 121 citations · Full text